Eumentis is a biopharmaceutical company that develops novel drugs for the treatment of neurodevelopmental and neurodegenerative disorders.The Company's lead product candidate, EM-036, is a novel proprietary nitro-aminoadamantane N-methyl-d-aspartate type-glutamate receptor (NMDAR) antagonist first b... Read more
This company has no teams yet